Pentosan Polysulfate Sodium (PPS)

PPS is a sulfated polysaccharide derived from beechwood, known for its anti-inflammatory properties. Historically used to treat bladder pain, recent studies suggest its potential in managing joint degeneration, such as osteoarthritis, by promoting cartilage restoration, recovering bone bruises, nourishing cartilage surfaces, and preventing degradation. However, caution should be exercised with patients who have allergies to components of PPS, are on blood-thinning medication, or have a personal or family history of pigmentary macular degeneration.

PPS, also known as Zilosul, is a groundbreaking polysulfate medication used to treat pain caused by various factors, including injury, inflammation, aging, disease, infection, or genetics. It reduces inflammation by decreasing key mediators and can result in decreased pain and cartilage degradation. Possible side effects include mild blood thinning, hair loss, injection site irritation, immune reactions, nausea, rash, or gastrointestinal distress. Currently in phase 3 trials in the US, PPS has been available in other countries for years.

There are two main forms of PPS, oral and injectable. Oral and injected pentosan polysulfate sodium (PPS) differ primarily in absorption, onset of action, and convenience. Oral PPS is absorbed through the digestive system, leading to slower onset and lower bioavailability due to gastrointestinal metabolism. It typically requires consistent, long-term use to achieve therapeutic effects and is convenient for patients as it can be taken at home.

In contrast, injected PPS is delivered directly into the bloodstream, allowing for faster absorption and more immediate effects, making it ideal for acute conditions. Injections generally have higher bioavailability and provide more precise delivery to target tissues, but they may cause local reactions at the injection site and require medical supervision or training for self-administration. While oral PPS is easier to manage over time, injected PPS may be preferred when quicker or more concentrated action is needed. The choice between the two forms depends on factors such as the severity of the condition, patient preference, and healthcare recommendations.